Bristol Myers Squibb

Director

• Accountable for the clinical contribution to the development of each indication strategy, including registrational and non-registrational studies, with the support of the CTPs and Clinical Scientists (CS) within the asset and/or indication.
• Responsible for managing clinical trial physician(s); attracting, developing and retaining top talent; ensuring appropriate training and mentoring of clinical trial physicians.
• May serve as CTP as necessary.
• Accountable in partnership with the Clinical Scientist for the design, execution, and analyses of each study led by the CTPs and CSs.
• Champions a quality-focused mindset and ensures adherence to GCP and compliance obligations for clinical conduct.
• Represents Clinical Development in both internal and external forums as the consulted authority for the disease area, including within Business Development function.
• Partners closely with KOLs in specific indications.
• Serves as Primary Clinical Representative in Regulatory interactions.

Senior Director, Global Clinical Development – Oncology

Clinical Research

• Responsible for implementation, planning, and execution of assigned clinical trial activities.
• Serves as Clinical Trial Lead for one or more trials.
• Successfully leads, plans, and executes trial level activities for multiple trials with minimal to moderate level of supervision.
• Provides scientific and clinical leadership to team of supporting Clinical Scientists (matrix leadership).
• Co-Leads study team meetings in partnership with GDO protocol manager; and collaborate with cross functional study team members.
• May support clinical development planning (collaboration with Clinical Development Lead/Clinical Trial Physician for provision and analysis of data to support future planning).
• Maintain a thorough understanding of assigned protocols and protocol requirements; educate supporting team members.
• Plan and lead the implementation all study startup/conduct/close-out activities as applicable.
• Evaluate innovative trial designs (collaboration with Medical Monitor/Clinical Development Lead).
• Protocol and ICF development process with minimal guidance; including writing, reviewing, adjudication/resolution of cross functional comments and ensuring high clinical quality (collaboration with Medical Writing).
• Site-facing activities such as training and serving as primary contact for clinical questions.
• Activities related to data generation and validation, including CRF design, clinical data review/query resolution; ensure consistent, quality data review by supporting CS team.
• Clinical data trend identification; provide trends and escalate questions to Medical Monitor.
• Develop clinical narrative plan; review clinical narratives.
• Provision of information required by Protocol Manager for development of trial budget, CRO scope of work, etc.
• Review development of site and CRA training materials and presentation at SIV and Investigator meetings and support on Study committee (e.g., DMC) activities.
• Drafting/review and validation of clinical study reports (CSRs) and clinical portions of Regulatory Documents (e.g., IB, DSUR, regulatory responses).
• Collaborate and serve as primary liaison between external partners for scientific advice.

Associate Director, Global Clinical Scientist – Cell Therapy

Supply Chain

• The GCO is responsible for delivering new and improved capabilities across People, Process, Technology, and Data, for their assigned area of responsibility.
• Acts as the primary point of contact for their associated GSC Pillar.
• Works across capabilities and capability owners to deliver a comprehensive pillar wide roadmap towards best-in-class ambitions.
• Serves as a member of the corresponding GSC Pillar leadership team, representing the capability model on behalf of Business Performance & Transformation and serving as a conduit between the GSC Pillar and Capability Owners and Leads.
• Provides leadership for large and highly complex capability programs, including matrix leadership of sub-programs.
• Defines process improvement and capability evolution roadmap across people, process, technology and data.
• Develop training content, key performance indicators (KPI’s) and change management to ensure user adoption and adherence to standard ways of working for deployment of new or uplifted capabilities.
• Develops and champions emerging technologies (e.g., AI, automation) that can create a competitive advantage and transform business models at an enterprise level.

Senior Director, Clinical Supply Chain Capability Owner

• Designs, manages, and improves cross-pillar capabilities enabling BMS Global Supply Chain (GSC).
• Collaborates with stakeholders to ensure consistent execution and drive towards best-in-class maturity.
• Delivers new and improved capabilities across People, Process, Technology, and Data.
• Ensures cross-functional alignment to deliver an integrated, unified S&OP plan.
• Leads cross-pillar end-to-end process standardization and transformation.
• Provides leadership for large and complex capability programs.
• Develops training content, key performance indicators (KPI’s), and change management.

Director, Global S&OP Capability Owner

• Provide purpose-driven leadership and direct oversight of the enterprise Fusion team, driving a clear vision, strategy, and roadmap that are fully aligned with and accelerate PDS and enterprise priorities
• Design and evolve a cross-functional operating model integrating business, product, data, engineering, and operations expertise that retains a competitive edge for PDS
• Establish standards for governance, decision rights, team structure, and performance management to enable scale
• Lead end-to-end digital transformation associated with business strategy, embedding data, AI, and digital capabilities into core processes
• Drive product-based, agile delivery models across the full lifecycle from opportunity definition through adoption and continuous improvement
• Translate business needs into scalable, secure, user-centered digital and AI solutions
• Ensure value realization, speed, and adoption through disciplined execution and strong stakeholder alignment
• Oversee enterprise data and AI capabilities enabling insight-driven decision making across PDS
• Integrate AI, automation, and digital tools into end-to-end workflows including business ownership of key platforms
• Define how human and AI capabilities operate together within critical business processes
• Establish data and digital product governance to ensure solutions are secure, compliant, ethical, and aligned to regulatory requirements
• Lead proactive stakeholder engagement across business units, building alignment, influencing enterprise decisions, and driving accountability for transformation outcomes

Executive Director, Digital Transformation, Fusion

Vice President

• The Global Program Lead (GPL) will serve as the “point of accountability” for two hematology assets.
• The program includes a growing marketed asset for anemia with ongoing pivotal studies and a potential first in class CELMoD for sickle cell disease.
• The GPL role is accountable for leading the Global Program Teams and orchestrating the design and execution of a global integrated program strategy from candidate nomination through drug development to successful launch and commercialization.
• The GPL develops, leads, and inspires a high performing matrix.
• They are responsible for cross-functional stakeholder relationships and input to ensure end to end understanding of upstream and downstream alignment and business implications for the strategy, and its evolution as emerging data and competitive insights unfold.
• In addition to leading these programs, the GPL will play a key role in the related disease area strategies (e.g., AML).
• Develops and manages product strategy and drug development programs to ensure approval and commercial success.
• Defines and executes the strategic integrated development plan (IDP) in partnership with the cross functional GPT members.
• Participates in regulatory filings (NDA, BLA filings), engaging with Health Authorities and/or Advisory Committees.
• Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design.
• Builds and maintains collaborative relationships with external stakeholders and appropriately incorporates insights and advice to maximize program impact.
• Actively supports Investor Relations and Public Affairs in managing external BMS communications.
• Integrates commercialization inputs and deliverables to design the program strategy that enables approval of meaningfully differentiated assets with potential to maximize asset value.
• Understands necessary commercial inputs needed to inform the end-to-end development process leading to regulatory approval and successful commercialization.
• Integrates market inputs into the integrated development plan, including clinical plans and labeling strategy; Appreciates translation of clinical data into claims and considerations for label development.
• Understands and contributes to development of forecasts and investment scenarios, how to assess risk and conduct valuations, and implications for decision making.
• Contributes to the development of brand hallmarks and brand strategy, understanding the relationship to clinical trial design.
• In partnership with Medical Affairs, supports development of KOL plans and engagements, and leverages KOL input in context of development programs and communicating evidence.
• Supports commercial needs and recommendations to guide CMC and GPS on trade packaging and commercial product.
• Utilizes various resources to design clinical trials that are competitively differentiating.
• Actively participates with Health Authorities in finalizing clinical design and adequate endpoints.
• Understands clinical trial operational complexities from study startup through enrollment, quality assurance, and study readout.
• Has an active role in analysis and/or interpretation of clinical data and translation into scientific communication strategy, including publications, and commercial strategy.
• Understands and reflects the impact of value and access inputs and value drivers in clinical trial design.
• Effectively collaborates with matrix functions by building trust and driving toward the collective success of the program.
• Gathers diverse perspectives to assess alternate resolutions and makes thoughtful, informed Enterprise decisions.
• Builds, leads and inspires high performing cross functional matrix team through a unified program strategy on behalf of our patients.
• Holds oneself and others accountable: takes initiative to address challenges, removes barriers, and holds others accountable for the collective success of the program outcomes and team collaboration.
• Leads with values, self-awareness, and humility, seeks feedback, includes integrity.

Vice President, Global Program Lead – Hematology Late Development

• Define and drive the integrated evidence generation strategy aligned with Medical Affairs and overall product strategy, spanning clinical trials (Phase II/IV), real-world evidence (RWE), non-interventional studies, registries, observational research, and health outcomes studies.
• Critically assess the design of research concepts to ensure they are strategically aligned to BMS priorities and can achieve the stated objectives.
• Lead or significantly contribute to protocol development, including Study design, Study objectives and endpoints, eligibility criteria, statistical considerations (in collaboration with Biostatistics), operational feasibility.
• Engage in peer-to-peer scientific dialogue with external research partners on collaboration studies to optimize key study design elements.
• Be accountable for delivering studies from concept ideation to governance approval and throughout the study lifecycle.
• Serve as a thought leader on evidence generation methodologies to ensure evidence plans are fit-for-purpose and impactful.
• Lead preparation and delivery of evidence generation proposals and updates including results to internal governance bodies and cross-functional stakeholders.
• Apply strong understanding of GCP, ICH guidelines, and clinical trial governance to ensure compliant and high-quality study execution.
• Partner with Clinical Operations and CROs to ensure studies are delivered on time, on budget, and with high data quality.
• Participate in advisory boards, steering committees, and scientific forums as necessary.
• Collaborate with cross-functional partners to ensure cohesive planning and execution of evidence generation activities across geographies and therapeutic areas.
• Oversee operational delivery of studies, ensuring scientific rigor, quality, compliance (GCP/SOP), timelines, and budgets.
• Contribute to scientific dissemination through publications, abstracts, congress presentations, and advisory boards.

Director, Global Medical Evidence Generation Lead, Oncology

• Strategic Leadership & Sterility Assurance Governance
• Embed control contamination and aseptic assurance strategy and aseptic-by-design principles into future processes and product development programs
• Lead remediation plans following regulatory observations, ensuring proactive installation of appropriate aseptic assurance standards (QMS and standard work) across the business
• Champion continuous improvement initiatives including KPI trending and capability development in aseptic and sterility assurance domains and process confirmations
• Own and periodically review BMS's Global CCS as a living document, ensuring it reflects current regulatory requirements
• Establish, own, and govern BMS's global sterility/aseptic assurance and CCS performance metrics framework, including KPI definitions, network-level escalation thresholds, trend analysis, and executive-level reporting cadence
• Support any implementation of BMS's Sterility Assurance Strategy
• Lead CMO support in establishing and executing annual Contamination Control Strategies (CCS) and Aseptic/Sterility Assurance Roadmaps
• Partner with CMOs for KPI analysis, trending, escalation, and gap assessments versus BMS standards (GQPs, QMS, FDA Guidance, etc.)
• Conduct due diligence activities during onboarding of new CMOs.
• Provide deep technical oversight of microbiological controls across pharmaceutical, biopharmaceutical, cell therapy, radiopharmaceutical and drug product manufacturing operations
• Lead the identification, qualification, and validation of terminal sterilization suppliers
• Provide expert technical guidance across product design, process controls, and organizational capabilities with a focus on microbiological controls
• Lead or oversee complex cross-site microbiological investigations, CAPA development, and systemic remediation efforts, ensuring robust root cause analysis and sustainable corrective actions
• Maintain in-depth knowledge of global regulations, guidance documents, and industry best practices related to sterility assurance, including: EU GMP, FDA, WHO, PDA, ASTM, ISPE, PhRMA , and BMS internal standards
• Support review of regulatory filings related to sterility assurance and microbiology
• Lead or actively support sterility assurance-related regulatory inspections globally, including direct engagement with FDA, EMA, MHRA, and other Health Authorities
• Lead assessment and adoption of new or updated regulations (e.g. Annex 1)
• Ensure CMOs and internal sites maintain inspection readiness at all times
• Lead or proactively influence external aseptic/sterility assurance trade associations and industry working groups (e.g., PDA, ISPE, PhRMA)
• Represent BMS and proactively influence external scientific and regulatory forums, including Health Authority advisory panels and industry standard-setting bodies
• Adapt and embed emerging best practices and industry innovations into BMS operations

Director, Microbiology Quality, Sterility Assurance

Artificial Intelligence

• Partner with scientists and research leaders to identify high-impact opportunities where AI can improve research speed, quality, consistency, traceability, and decision-making.
• Help shape multi-year GenAI strategies, lead workstreams, and establish reusable building blocks - agentic frameworks, evaluation harnesses, retrieval and grounding components, tool servers, prompt and policy libraries, and provenance infrastructure - on which research programs build.
• Architect and personally implement the agentic system-of-systems that executes complex, long-horizon scientific workflows across research, including target evidence assembly, indication rationale construction, biomarker interpretation, translational synthesis, literature and evidence triangulation, and decision support, with explicit attention to inter-agent coordination, state and memory management, verification, recovery from intermediate failure, and lifecycle governance of agents in production.
• Establish the scientifically rigorous evaluation, benchmarking, and reliability standards that critical research AI systems expected to meet, including curated benchmark datasets, expert-reviewed reference standards, rubric-based assessments, hallucination and grounding metrics, calibration of uncertainty, longitudinal monitoring, regression gating in production, and the governance under which those standards are applied.
• Design mechanisms for incorporating expert feedback, scientific rationale, provenance, and research context into AI workflows so that systems and institutional knowledge improve over time.
• Collaborate with engineering, data, IT, security, legal, vendor, and platform teams to ensure prototypes are designed with appropriate governance, integration paths, and scalability in mind.
• Communicate AI opportunities, risks, limitations, evidence quality, and results clearly to scientific, technical, and executive audiences.
• Stay current with emerging AI methods, tools, vendors, and industry practices, and assess where they can create practical value for Research.

Principal Research AI Innovation Lead

• Drives innovative and efficient study design.
• Develops study designs that address study objectives that will support regulatory approval, medical research and market access.
• Independently leads, initiates, and oversees the statistical support for the development of compounds within Oncology.
• Provides guidance and management to statisticians to ensure high quality and timely deliverables.
• Effectively engages as a matrix team member on high level development teams, to act as a scientific and strategic partner in the drug development process.
• Presents and defends complex statistical solutions to all levels of BMS governance, key stakeholders and external regulatory bodies in a clear, concise, complete, and transparent manner that provide influence on key decisions.
• Contributes to Clinical Development Plans, leads GBDS related submission activities, and post-submission strategies/ preparations/defenses.
• Provides statistical support and leadership to address health authority request, publication, presentation, and other public release of information.
• Compliant with BMS processes and SOPs, adherence to global and project standards within an indication or therapeutic area and responsible for quality of deliverable.
• Contributes to creation/maintenance of and provide training on statistical topics departmental SOPs.
• Provides guidance and management to statisticians to ensure high quality and timely deliverables.
• Manages a functional or project budget, and has authority to allocate company resources according to project needs, set priorities, and ensure consistency and adherence to standards therein.
• Represents BMS at professional societies, and in industry-wide technical discussions.
• Contributes to the statistical community of practice.
• Provides active coaching to biostatistical team members when developing solutions to problems.
• Effectively communicates the GBDS Mission and Vision in a fashion that generates pride, excitement and commitment within GBDS.
• Enables a culture of inclusiveness, respect for diversity, compliance with process and allows for the questioning and challenging of others in a respectful and constructive manner.

Financial Planning and Analysis

• Act as a change agent with the Finance Director and Finance Leadership to shape long-range plans, deliver robust analysis, and inform strategic decisions
• Serve as Finance Lead to the External Manufacturing Business Unit and Virtual Plant Leadership Teams, providing strategic insight to guide business and operational decisions
• Lead monthly, quarterly, and annual performance analysis across actuals, budget, forecast, and prior periods, identifying key drivers, risks, and root causes
• Develop concise commentary on financial variances, highlighting risks, opportunities, and emerging trends
• Create and maintain dashboards, reports, and presentations to support execution of the External Manufacturing business plan
• Ensure data accuracy and consistency across financial systems and reports
• Influence large teams and global partners to achieve BMS goals
• Support internal and external audits as required

Associate Director – External Manufacturing Finance

Compliance

• work transforming lives of patients• collaborating with teams to optimize production lines• applying individual talents• conducting work far beyond ordinary• ensuring balance and flexibility in work environment

Associate Director, Regulatory Affairs CMC

Therapist

• The Global Program Lead (GPL) will serve as the “point of accountability” for two novel cell therapies in multiple myeloma.
• These programs include ongoing pivotal studies with potential to redefine the treatment paradigm.
• The GPL role is accountable for leading the Global Program Teams and orchestrating the design and execution of a global integrated program strategy from candidate nomination through drug development to successful launch and commercialization.
• The GPL develops, leads, and inspires a high performing matrix.
• They are responsible for cross-functional stakeholder relationships and input to ensure end to end understanding of upstream and downstream alignment and business implications for the strategy, and its evolution as emerging data and competitive insights unfold.
• Integrates market inputs into the integrated development plan, including clinical plans and labeling strategy; appreciates translation of clinical data into claims and considerations for label development.

VP, Global Program Lead – Cell Therapy

• Develop AI/ML models to predict structural biomolecular interactions for novel modalities leveraging protein-protein interactions.
• Design innovative AI/ML approaches to predict protein cooperativity, affinity & other biological properties based on structures.
• Develop co-folding models that incorporate structural and non-structural priors using combinations of public and proprietary BMS data.
• Develop AI/ML models that leverage chemoproteomics data contributing to the generation of novel druggability hypotheses for hard-to-drug targets.
• Author scientific reports, and present methods, results, and conclusions to publishable standard.
• Contribute to the planning and execution of collaborative projects with leading academic and commercial research groups worldwide.

Senior Scientist, AI Computational Structural Biology

• Lead safety activities and benefit-risk strategies for assigned BMS compounds/ program and chair the product Safety Management Team(s).
• Oversee, Prepare, and/or Review aggregate safety review documents as well as safety sections of relevant clinical trial documents and regulatory filings.
• Lead team in the evaluation & management of signals emerging from any data source.
• Develop strategy for signal evaluation and document outcome.
• Lead safety labeling activities for assigned products/ program.
• Participate/ Provide input at cross-functional labeling team meetings and provide regional safety labeling support.
• Lead process improvement projects.
• Assist the MSA Therapeutic Area (TA) Head/Lead in developing and maintaining state-of-the-art PV processes and procedures within BMS R&D and WWPS.
• Promote collegiality and teamwork among peers. Mentor/Support colleagues as a positive change agent.